Global Hyperimmune Serum Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Hyperimmune Serum Industry Forecast” looks at past sales and reviews total world Hyperimmune Serum sales in 2022, providing a comprehensive analysis by region and market sector of projected Hyperimmune Serum sales for 2023 through 2029. With Hyperimmune Serum sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hyperimmune Serum industry.
This Insight Report provides a comprehensive analysis of the global Hyperimmune Serum landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hyperimmune Serum portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hyperimmune Serum market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hyperimmune Serum and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hyperimmune Serum.
The global Hyperimmune Serum market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Hyperimmune Serum is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Hyperimmune Serum is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Hyperimmune Serum is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Hyperimmune Serum players cover CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Hyperimmune Serum market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Hyperimmune Serum market?
What factors are driving Hyperimmune Serum market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hyperimmune Serum market opportunities vary by end market size?
How does Hyperimmune Serum break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Hyperimmune Serum Industry Forecast” looks at past sales and reviews total world Hyperimmune Serum sales in 2022, providing a comprehensive analysis by region and market sector of projected Hyperimmune Serum sales for 2023 through 2029. With Hyperimmune Serum sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hyperimmune Serum industry.
This Insight Report provides a comprehensive analysis of the global Hyperimmune Serum landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hyperimmune Serum portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hyperimmune Serum market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hyperimmune Serum and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hyperimmune Serum.
The global Hyperimmune Serum market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Hyperimmune Serum is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Hyperimmune Serum is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Hyperimmune Serum is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Hyperimmune Serum players cover CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Hyperimmune Serum market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Hepatitis B Immunoglobulins
- Rabies Immunoglobulins
- Tetanus Immunoglobulins
- Rho(D) Immunoglobulins
- Other
- Government Institutions
- Private Sector
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL Behring
- Grifols
- Biotest
- Kedrion
- CBPO
- Emergent (Cangene)
- Kamada
- CNBG
- Hualan Bio
- Shanghai RAAS
- Sichuan Yuanda Shuyang
- ADMA Biologics
What is the 10-year outlook for the global Hyperimmune Serum market?
What factors are driving Hyperimmune Serum market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hyperimmune Serum market opportunities vary by end market size?
How does Hyperimmune Serum break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hyperimmune Serum Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hyperimmune Serum by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hyperimmune Serum by Country/Region, 2018, 2022 & 2029
2.2 Hyperimmune Serum Segment by Type
2.2.1 Hepatitis B Immunoglobulins
2.2.2 Rabies Immunoglobulins
2.2.3 Tetanus Immunoglobulins
2.2.4 Rho(D) Immunoglobulins
2.2.5 Other
2.3 Hyperimmune Serum Sales by Type
2.3.1 Global Hyperimmune Serum Sales Market Share by Type (2018-2023)
2.3.2 Global Hyperimmune Serum Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hyperimmune Serum Sale Price by Type (2018-2023)
2.4 Hyperimmune Serum Segment by Application
2.4.1 Government Institutions
2.4.2 Private Sector
2.4.3 Other
2.5 Hyperimmune Serum Sales by Application
2.5.1 Global Hyperimmune Serum Sale Market Share by Application (2018-2023)
2.5.2 Global Hyperimmune Serum Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hyperimmune Serum Sale Price by Application (2018-2023)
3 GLOBAL HYPERIMMUNE SERUM BY COMPANY
3.1 Global Hyperimmune Serum Breakdown Data by Company
3.1.1 Global Hyperimmune Serum Annual Sales by Company (2018-2023)
3.1.2 Global Hyperimmune Serum Sales Market Share by Company (2018-2023)
3.2 Global Hyperimmune Serum Annual Revenue by Company (2018-2023)
3.2.1 Global Hyperimmune Serum Revenue by Company (2018-2023)
3.2.2 Global Hyperimmune Serum Revenue Market Share by Company (2018-2023)
3.3 Global Hyperimmune Serum Sale Price by Company
3.4 Key Manufacturers Hyperimmune Serum Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hyperimmune Serum Product Location Distribution
3.4.2 Players Hyperimmune Serum Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HYPERIMMUNE SERUM BY GEOGRAPHIC REGION
4.1 World Historic Hyperimmune Serum Market Size by Geographic Region (2018-2023)
4.1.1 Global Hyperimmune Serum Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hyperimmune Serum Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hyperimmune Serum Market Size by Country/Region (2018-2023)
4.2.1 Global Hyperimmune Serum Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hyperimmune Serum Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hyperimmune Serum Sales Growth
4.4 APAC Hyperimmune Serum Sales Growth
4.5 Europe Hyperimmune Serum Sales Growth
4.6 Middle East & Africa Hyperimmune Serum Sales Growth
5 AMERICAS
5.1 Americas Hyperimmune Serum Sales by Country
5.1.1 Americas Hyperimmune Serum Sales by Country (2018-2023)
5.1.2 Americas Hyperimmune Serum Revenue by Country (2018-2023)
5.2 Americas Hyperimmune Serum Sales by Type
5.3 Americas Hyperimmune Serum Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hyperimmune Serum Sales by Region
6.1.1 APAC Hyperimmune Serum Sales by Region (2018-2023)
6.1.2 APAC Hyperimmune Serum Revenue by Region (2018-2023)
6.2 APAC Hyperimmune Serum Sales by Type
6.3 APAC Hyperimmune Serum Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hyperimmune Serum by Country
7.1.1 Europe Hyperimmune Serum Sales by Country (2018-2023)
7.1.2 Europe Hyperimmune Serum Revenue by Country (2018-2023)
7.2 Europe Hyperimmune Serum Sales by Type
7.3 Europe Hyperimmune Serum Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hyperimmune Serum by Country
8.1.1 Middle East & Africa Hyperimmune Serum Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hyperimmune Serum Revenue by Country (2018-2023)
8.2 Middle East & Africa Hyperimmune Serum Sales by Type
8.3 Middle East & Africa Hyperimmune Serum Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hyperimmune Serum
10.3 Manufacturing Process Analysis of Hyperimmune Serum
10.4 Industry Chain Structure of Hyperimmune Serum
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hyperimmune Serum Distributors
11.3 Hyperimmune Serum Customer
12 WORLD FORECAST REVIEW FOR HYPERIMMUNE SERUM BY GEOGRAPHIC REGION
12.1 Global Hyperimmune Serum Market Size Forecast by Region
12.1.1 Global Hyperimmune Serum Forecast by Region (2024-2029)
12.1.2 Global Hyperimmune Serum Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hyperimmune Serum Forecast by Type
12.7 Global Hyperimmune Serum Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Hyperimmune Serum Product Portfolios and Specifications
13.1.3 CSL Behring Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Hyperimmune Serum Product Portfolios and Specifications
13.2.3 Grifols Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Biotest
13.3.1 Biotest Company Information
13.3.2 Biotest Hyperimmune Serum Product Portfolios and Specifications
13.3.3 Biotest Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biotest Main Business Overview
13.3.5 Biotest Latest Developments
13.4 Kedrion
13.4.1 Kedrion Company Information
13.4.2 Kedrion Hyperimmune Serum Product Portfolios and Specifications
13.4.3 Kedrion Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Kedrion Main Business Overview
13.4.5 Kedrion Latest Developments
13.5 CBPO
13.5.1 CBPO Company Information
13.5.2 CBPO Hyperimmune Serum Product Portfolios and Specifications
13.5.3 CBPO Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CBPO Main Business Overview
13.5.5 CBPO Latest Developments
13.6 Emergent (Cangene)
13.6.1 Emergent (Cangene) Company Information
13.6.2 Emergent (Cangene) Hyperimmune Serum Product Portfolios and Specifications
13.6.3 Emergent (Cangene) Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Emergent (Cangene) Main Business Overview
13.6.5 Emergent (Cangene) Latest Developments
13.7 Kamada
13.7.1 Kamada Company Information
13.7.2 Kamada Hyperimmune Serum Product Portfolios and Specifications
13.7.3 Kamada Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Kamada Main Business Overview
13.7.5 Kamada Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Hyperimmune Serum Product Portfolios and Specifications
13.8.3 CNBG Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Hualan Bio
13.9.1 Hualan Bio Company Information
13.9.2 Hualan Bio Hyperimmune Serum Product Portfolios and Specifications
13.9.3 Hualan Bio Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hualan Bio Main Business Overview
13.9.5 Hualan Bio Latest Developments
13.10 Shanghai RAAS
13.10.1 Shanghai RAAS Company Information
13.10.2 Shanghai RAAS Hyperimmune Serum Product Portfolios and Specifications
13.10.3 Shanghai RAAS Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shanghai RAAS Main Business Overview
13.10.5 Shanghai RAAS Latest Developments
13.11 Sichuan Yuanda Shuyang
13.11.1 Sichuan Yuanda Shuyang Company Information
13.11.2 Sichuan Yuanda Shuyang Hyperimmune Serum Product Portfolios and Specifications
13.11.3 Sichuan Yuanda Shuyang Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sichuan Yuanda Shuyang Main Business Overview
13.11.5 Sichuan Yuanda Shuyang Latest Developments
13.12 ADMA Biologics
13.12.1 ADMA Biologics Company Information
13.12.2 ADMA Biologics Hyperimmune Serum Product Portfolios and Specifications
13.12.3 ADMA Biologics Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 ADMA Biologics Main Business Overview
13.12.5 ADMA Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hyperimmune Serum Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hyperimmune Serum by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hyperimmune Serum by Country/Region, 2018, 2022 & 2029
2.2 Hyperimmune Serum Segment by Type
2.2.1 Hepatitis B Immunoglobulins
2.2.2 Rabies Immunoglobulins
2.2.3 Tetanus Immunoglobulins
2.2.4 Rho(D) Immunoglobulins
2.2.5 Other
2.3 Hyperimmune Serum Sales by Type
2.3.1 Global Hyperimmune Serum Sales Market Share by Type (2018-2023)
2.3.2 Global Hyperimmune Serum Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hyperimmune Serum Sale Price by Type (2018-2023)
2.4 Hyperimmune Serum Segment by Application
2.4.1 Government Institutions
2.4.2 Private Sector
2.4.3 Other
2.5 Hyperimmune Serum Sales by Application
2.5.1 Global Hyperimmune Serum Sale Market Share by Application (2018-2023)
2.5.2 Global Hyperimmune Serum Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hyperimmune Serum Sale Price by Application (2018-2023)
3 GLOBAL HYPERIMMUNE SERUM BY COMPANY
3.1 Global Hyperimmune Serum Breakdown Data by Company
3.1.1 Global Hyperimmune Serum Annual Sales by Company (2018-2023)
3.1.2 Global Hyperimmune Serum Sales Market Share by Company (2018-2023)
3.2 Global Hyperimmune Serum Annual Revenue by Company (2018-2023)
3.2.1 Global Hyperimmune Serum Revenue by Company (2018-2023)
3.2.2 Global Hyperimmune Serum Revenue Market Share by Company (2018-2023)
3.3 Global Hyperimmune Serum Sale Price by Company
3.4 Key Manufacturers Hyperimmune Serum Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hyperimmune Serum Product Location Distribution
3.4.2 Players Hyperimmune Serum Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HYPERIMMUNE SERUM BY GEOGRAPHIC REGION
4.1 World Historic Hyperimmune Serum Market Size by Geographic Region (2018-2023)
4.1.1 Global Hyperimmune Serum Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hyperimmune Serum Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hyperimmune Serum Market Size by Country/Region (2018-2023)
4.2.1 Global Hyperimmune Serum Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hyperimmune Serum Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hyperimmune Serum Sales Growth
4.4 APAC Hyperimmune Serum Sales Growth
4.5 Europe Hyperimmune Serum Sales Growth
4.6 Middle East & Africa Hyperimmune Serum Sales Growth
5 AMERICAS
5.1 Americas Hyperimmune Serum Sales by Country
5.1.1 Americas Hyperimmune Serum Sales by Country (2018-2023)
5.1.2 Americas Hyperimmune Serum Revenue by Country (2018-2023)
5.2 Americas Hyperimmune Serum Sales by Type
5.3 Americas Hyperimmune Serum Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hyperimmune Serum Sales by Region
6.1.1 APAC Hyperimmune Serum Sales by Region (2018-2023)
6.1.2 APAC Hyperimmune Serum Revenue by Region (2018-2023)
6.2 APAC Hyperimmune Serum Sales by Type
6.3 APAC Hyperimmune Serum Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hyperimmune Serum by Country
7.1.1 Europe Hyperimmune Serum Sales by Country (2018-2023)
7.1.2 Europe Hyperimmune Serum Revenue by Country (2018-2023)
7.2 Europe Hyperimmune Serum Sales by Type
7.3 Europe Hyperimmune Serum Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hyperimmune Serum by Country
8.1.1 Middle East & Africa Hyperimmune Serum Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hyperimmune Serum Revenue by Country (2018-2023)
8.2 Middle East & Africa Hyperimmune Serum Sales by Type
8.3 Middle East & Africa Hyperimmune Serum Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hyperimmune Serum
10.3 Manufacturing Process Analysis of Hyperimmune Serum
10.4 Industry Chain Structure of Hyperimmune Serum
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hyperimmune Serum Distributors
11.3 Hyperimmune Serum Customer
12 WORLD FORECAST REVIEW FOR HYPERIMMUNE SERUM BY GEOGRAPHIC REGION
12.1 Global Hyperimmune Serum Market Size Forecast by Region
12.1.1 Global Hyperimmune Serum Forecast by Region (2024-2029)
12.1.2 Global Hyperimmune Serum Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hyperimmune Serum Forecast by Type
12.7 Global Hyperimmune Serum Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Hyperimmune Serum Product Portfolios and Specifications
13.1.3 CSL Behring Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Hyperimmune Serum Product Portfolios and Specifications
13.2.3 Grifols Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Biotest
13.3.1 Biotest Company Information
13.3.2 Biotest Hyperimmune Serum Product Portfolios and Specifications
13.3.3 Biotest Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biotest Main Business Overview
13.3.5 Biotest Latest Developments
13.4 Kedrion
13.4.1 Kedrion Company Information
13.4.2 Kedrion Hyperimmune Serum Product Portfolios and Specifications
13.4.3 Kedrion Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Kedrion Main Business Overview
13.4.5 Kedrion Latest Developments
13.5 CBPO
13.5.1 CBPO Company Information
13.5.2 CBPO Hyperimmune Serum Product Portfolios and Specifications
13.5.3 CBPO Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CBPO Main Business Overview
13.5.5 CBPO Latest Developments
13.6 Emergent (Cangene)
13.6.1 Emergent (Cangene) Company Information
13.6.2 Emergent (Cangene) Hyperimmune Serum Product Portfolios and Specifications
13.6.3 Emergent (Cangene) Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Emergent (Cangene) Main Business Overview
13.6.5 Emergent (Cangene) Latest Developments
13.7 Kamada
13.7.1 Kamada Company Information
13.7.2 Kamada Hyperimmune Serum Product Portfolios and Specifications
13.7.3 Kamada Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Kamada Main Business Overview
13.7.5 Kamada Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Hyperimmune Serum Product Portfolios and Specifications
13.8.3 CNBG Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Hualan Bio
13.9.1 Hualan Bio Company Information
13.9.2 Hualan Bio Hyperimmune Serum Product Portfolios and Specifications
13.9.3 Hualan Bio Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hualan Bio Main Business Overview
13.9.5 Hualan Bio Latest Developments
13.10 Shanghai RAAS
13.10.1 Shanghai RAAS Company Information
13.10.2 Shanghai RAAS Hyperimmune Serum Product Portfolios and Specifications
13.10.3 Shanghai RAAS Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shanghai RAAS Main Business Overview
13.10.5 Shanghai RAAS Latest Developments
13.11 Sichuan Yuanda Shuyang
13.11.1 Sichuan Yuanda Shuyang Company Information
13.11.2 Sichuan Yuanda Shuyang Hyperimmune Serum Product Portfolios and Specifications
13.11.3 Sichuan Yuanda Shuyang Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sichuan Yuanda Shuyang Main Business Overview
13.11.5 Sichuan Yuanda Shuyang Latest Developments
13.12 ADMA Biologics
13.12.1 ADMA Biologics Company Information
13.12.2 ADMA Biologics Hyperimmune Serum Product Portfolios and Specifications
13.12.3 ADMA Biologics Hyperimmune Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 ADMA Biologics Main Business Overview
13.12.5 ADMA Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hyperimmune Serum Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hyperimmune Serum Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hepatitis B Immunoglobulins
Table 4. Major Players of Rabies Immunoglobulins
Table 5. Major Players of Tetanus Immunoglobulins
Table 6. Major Players of Rho(D) Immunoglobulins
Table 7. Major Players of Other
Table 8. Global Hyperimmune Serum Sales by Type (2018-2023) & (Kiloton)
Table 9. Global Hyperimmune Serum Sales Market Share by Type (2018-2023)
Table 10. Global Hyperimmune Serum Revenue by Type (2018-2023) & ($ million)
Table 11. Global Hyperimmune Serum Revenue Market Share by Type (2018-2023)
Table 12. Global Hyperimmune Serum Sale Price by Type (2018-2023) & (US$/Ton)
Table 13. Global Hyperimmune Serum Sales by Application (2018-2023) & (Kiloton)
Table 14. Global Hyperimmune Serum Sales Market Share by Application (2018-2023)
Table 15. Global Hyperimmune Serum Revenue by Application (2018-2023)
Table 16. Global Hyperimmune Serum Revenue Market Share by Application (2018-2023)
Table 17. Global Hyperimmune Serum Sale Price by Application (2018-2023) & (US$/Ton)
Table 18. Global Hyperimmune Serum Sales by Company (2018-2023) & (Kiloton)
Table 19. Global Hyperimmune Serum Sales Market Share by Company (2018-2023)
Table 20. Global Hyperimmune Serum Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Hyperimmune Serum Revenue Market Share by Company (2018-2023)
Table 22. Global Hyperimmune Serum Sale Price by Company (2018-2023) & (US$/Ton)
Table 23. Key Manufacturers Hyperimmune Serum Producing Area Distribution and Sales Area
Table 24. Players Hyperimmune Serum Products Offered
Table 25. Hyperimmune Serum Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Hyperimmune Serum Sales by Geographic Region (2018-2023) & (Kiloton)
Table 29. Global Hyperimmune Serum Sales Market Share Geographic Region (2018-2023)
Table 30. Global Hyperimmune Serum Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Hyperimmune Serum Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Hyperimmune Serum Sales by Country/Region (2018-2023) & (Kiloton)
Table 33. Global Hyperimmune Serum Sales Market Share by Country/Region (2018-2023)
Table 34. Global Hyperimmune Serum Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Hyperimmune Serum Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Hyperimmune Serum Sales by Country (2018-2023) & (Kiloton)
Table 37. Americas Hyperimmune Serum Sales Market Share by Country (2018-2023)
Table 38. Americas Hyperimmune Serum Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Hyperimmune Serum Revenue Market Share by Country (2018-2023)
Table 40. Americas Hyperimmune Serum Sales by Type (2018-2023) & (Kiloton)
Table 41. Americas Hyperimmune Serum Sales by Application (2018-2023) & (Kiloton)
Table 42. APAC Hyperimmune Serum Sales by Region (2018-2023) & (Kiloton)
Table 43. APAC Hyperimmune Serum Sales Market Share by Region (2018-2023)
Table 44. APAC Hyperimmune Serum Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Hyperimmune Serum Revenue Market Share by Region (2018-2023)
Table 46. APAC Hyperimmune Serum Sales by Type (2018-2023) & (Kiloton)
Table 47. APAC Hyperimmune Serum Sales by Application (2018-2023) & (Kiloton)
Table 48. Europe Hyperimmune Serum Sales by Country (2018-2023) & (Kiloton)
Table 49. Europe Hyperimmune Serum Sales Market Share by Country (2018-2023)
Table 50. Europe Hyperimmune Serum Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Hyperimmune Serum Revenue Market Share by Country (2018-2023)
Table 52. Europe Hyperimmune Serum Sales by Type (2018-2023) & (Kiloton)
Table 53. Europe Hyperimmune Serum Sales by Application (2018-2023) & (Kiloton)
Table 54. Middle East & Africa Hyperimmune Serum Sales by Country (2018-2023) & (Kiloton)
Table 55. Middle East & Africa Hyperimmune Serum Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Hyperimmune Serum Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Hyperimmune Serum Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Hyperimmune Serum Sales by Type (2018-2023) & (Kiloton)
Table 59. Middle East & Africa Hyperimmune Serum Sales by Application (2018-2023) & (Kiloton)
Table 60. Key Market Drivers & Growth Opportunities of Hyperimmune Serum
Table 61. Key Market Challenges & Risks of Hyperimmune Serum
Table 62. Key Industry Trends of Hyperimmune Serum
Table 63. Hyperimmune Serum Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Hyperimmune Serum Distributors List
Table 66. Hyperimmune Serum Customer List
Table 67. Global Hyperimmune Serum Sales Forecast by Region (2024-2029) & (Kiloton)
Table 68. Global Hyperimmune Serum Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Hyperimmune Serum Sales Forecast by Country (2024-2029) & (Kiloton)
Table 70. Americas Hyperimmune Serum Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Hyperimmune Serum Sales Forecast by Region (2024-2029) & (Kiloton)
Table 72. APAC Hyperimmune Serum Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Hyperimmune Serum Sales Forecast by Country (2024-2029) & (Kiloton)
Table 74. Europe Hyperimmune Serum Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Hyperimmune Serum Sales Forecast by Country (2024-2029) & (Kiloton)
Table 76. Middle East & Africa Hyperimmune Serum Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Hyperimmune Serum Sales Forecast by Type (2024-2029) & (Kiloton)
Table 78. Global Hyperimmune Serum Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Hyperimmune Serum Sales Forecast by Application (2024-2029) & (Kiloton)
Table 80. Global Hyperimmune Serum Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. CSL Behring Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 82. CSL Behring Hyperimmune Serum Product Portfolios and Specifications
Table 83. CSL Behring Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 84. CSL Behring Main Business
Table 85. CSL Behring Latest Developments
Table 86. Grifols Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 87. Grifols Hyperimmune Serum Product Portfolios and Specifications
Table 88. Grifols Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 89. Grifols Main Business
Table 90. Grifols Latest Developments
Table 91. Biotest Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 92. Biotest Hyperimmune Serum Product Portfolios and Specifications
Table 93. Biotest Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 94. Biotest Main Business
Table 95. Biotest Latest Developments
Table 96. Kedrion Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 97. Kedrion Hyperimmune Serum Product Portfolios and Specifications
Table 98. Kedrion Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 99. Kedrion Main Business
Table 100. Kedrion Latest Developments
Table 101. CBPO Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 102. CBPO Hyperimmune Serum Product Portfolios and Specifications
Table 103. CBPO Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 104. CBPO Main Business
Table 105. CBPO Latest Developments
Table 106. Emergent (Cangene) Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 107. Emergent (Cangene) Hyperimmune Serum Product Portfolios and Specifications
Table 108. Emergent (Cangene) Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 109. Emergent (Cangene) Main Business
Table 110. Emergent (Cangene) Latest Developments
Table 111. Kamada Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 112. Kamada Hyperimmune Serum Product Portfolios and Specifications
Table 113. Kamada Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 114. Kamada Main Business
Table 115. Kamada Latest Developments
Table 116. CNBG Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 117. CNBG Hyperimmune Serum Product Portfolios and Specifications
Table 118. CNBG Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 119. CNBG Main Business
Table 120. CNBG Latest Developments
Table 121. Hualan Bio Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 122. Hualan Bio Hyperimmune Serum Product Portfolios and Specifications
Table 123. Hualan Bio Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 124. Hualan Bio Main Business
Table 125. Hualan Bio Latest Developments
Table 126. Shanghai RAAS Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 127. Shanghai RAAS Hyperimmune Serum Product Portfolios and Specifications
Table 128. Shanghai RAAS Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 129. Shanghai RAAS Main Business
Table 130. Shanghai RAAS Latest Developments
Table 131. Sichuan Yuanda Shuyang Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 132. Sichuan Yuanda Shuyang Hyperimmune Serum Product Portfolios and Specifications
Table 133. Sichuan Yuanda Shuyang Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 134. Sichuan Yuanda Shuyang Main Business
Table 135. Sichuan Yuanda Shuyang Latest Developments
Table 136. ADMA Biologics Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 137. ADMA Biologics Hyperimmune Serum Product Portfolios and Specifications
Table 138. ADMA Biologics Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 139. ADMA Biologics Main Business
Table 140. ADMA Biologics Latest Developments
Table 1. Hyperimmune Serum Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hyperimmune Serum Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hepatitis B Immunoglobulins
Table 4. Major Players of Rabies Immunoglobulins
Table 5. Major Players of Tetanus Immunoglobulins
Table 6. Major Players of Rho(D) Immunoglobulins
Table 7. Major Players of Other
Table 8. Global Hyperimmune Serum Sales by Type (2018-2023) & (Kiloton)
Table 9. Global Hyperimmune Serum Sales Market Share by Type (2018-2023)
Table 10. Global Hyperimmune Serum Revenue by Type (2018-2023) & ($ million)
Table 11. Global Hyperimmune Serum Revenue Market Share by Type (2018-2023)
Table 12. Global Hyperimmune Serum Sale Price by Type (2018-2023) & (US$/Ton)
Table 13. Global Hyperimmune Serum Sales by Application (2018-2023) & (Kiloton)
Table 14. Global Hyperimmune Serum Sales Market Share by Application (2018-2023)
Table 15. Global Hyperimmune Serum Revenue by Application (2018-2023)
Table 16. Global Hyperimmune Serum Revenue Market Share by Application (2018-2023)
Table 17. Global Hyperimmune Serum Sale Price by Application (2018-2023) & (US$/Ton)
Table 18. Global Hyperimmune Serum Sales by Company (2018-2023) & (Kiloton)
Table 19. Global Hyperimmune Serum Sales Market Share by Company (2018-2023)
Table 20. Global Hyperimmune Serum Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Hyperimmune Serum Revenue Market Share by Company (2018-2023)
Table 22. Global Hyperimmune Serum Sale Price by Company (2018-2023) & (US$/Ton)
Table 23. Key Manufacturers Hyperimmune Serum Producing Area Distribution and Sales Area
Table 24. Players Hyperimmune Serum Products Offered
Table 25. Hyperimmune Serum Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Hyperimmune Serum Sales by Geographic Region (2018-2023) & (Kiloton)
Table 29. Global Hyperimmune Serum Sales Market Share Geographic Region (2018-2023)
Table 30. Global Hyperimmune Serum Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Hyperimmune Serum Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Hyperimmune Serum Sales by Country/Region (2018-2023) & (Kiloton)
Table 33. Global Hyperimmune Serum Sales Market Share by Country/Region (2018-2023)
Table 34. Global Hyperimmune Serum Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Hyperimmune Serum Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Hyperimmune Serum Sales by Country (2018-2023) & (Kiloton)
Table 37. Americas Hyperimmune Serum Sales Market Share by Country (2018-2023)
Table 38. Americas Hyperimmune Serum Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Hyperimmune Serum Revenue Market Share by Country (2018-2023)
Table 40. Americas Hyperimmune Serum Sales by Type (2018-2023) & (Kiloton)
Table 41. Americas Hyperimmune Serum Sales by Application (2018-2023) & (Kiloton)
Table 42. APAC Hyperimmune Serum Sales by Region (2018-2023) & (Kiloton)
Table 43. APAC Hyperimmune Serum Sales Market Share by Region (2018-2023)
Table 44. APAC Hyperimmune Serum Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Hyperimmune Serum Revenue Market Share by Region (2018-2023)
Table 46. APAC Hyperimmune Serum Sales by Type (2018-2023) & (Kiloton)
Table 47. APAC Hyperimmune Serum Sales by Application (2018-2023) & (Kiloton)
Table 48. Europe Hyperimmune Serum Sales by Country (2018-2023) & (Kiloton)
Table 49. Europe Hyperimmune Serum Sales Market Share by Country (2018-2023)
Table 50. Europe Hyperimmune Serum Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Hyperimmune Serum Revenue Market Share by Country (2018-2023)
Table 52. Europe Hyperimmune Serum Sales by Type (2018-2023) & (Kiloton)
Table 53. Europe Hyperimmune Serum Sales by Application (2018-2023) & (Kiloton)
Table 54. Middle East & Africa Hyperimmune Serum Sales by Country (2018-2023) & (Kiloton)
Table 55. Middle East & Africa Hyperimmune Serum Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Hyperimmune Serum Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Hyperimmune Serum Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Hyperimmune Serum Sales by Type (2018-2023) & (Kiloton)
Table 59. Middle East & Africa Hyperimmune Serum Sales by Application (2018-2023) & (Kiloton)
Table 60. Key Market Drivers & Growth Opportunities of Hyperimmune Serum
Table 61. Key Market Challenges & Risks of Hyperimmune Serum
Table 62. Key Industry Trends of Hyperimmune Serum
Table 63. Hyperimmune Serum Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Hyperimmune Serum Distributors List
Table 66. Hyperimmune Serum Customer List
Table 67. Global Hyperimmune Serum Sales Forecast by Region (2024-2029) & (Kiloton)
Table 68. Global Hyperimmune Serum Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Hyperimmune Serum Sales Forecast by Country (2024-2029) & (Kiloton)
Table 70. Americas Hyperimmune Serum Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Hyperimmune Serum Sales Forecast by Region (2024-2029) & (Kiloton)
Table 72. APAC Hyperimmune Serum Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Hyperimmune Serum Sales Forecast by Country (2024-2029) & (Kiloton)
Table 74. Europe Hyperimmune Serum Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Hyperimmune Serum Sales Forecast by Country (2024-2029) & (Kiloton)
Table 76. Middle East & Africa Hyperimmune Serum Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Hyperimmune Serum Sales Forecast by Type (2024-2029) & (Kiloton)
Table 78. Global Hyperimmune Serum Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Hyperimmune Serum Sales Forecast by Application (2024-2029) & (Kiloton)
Table 80. Global Hyperimmune Serum Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. CSL Behring Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 82. CSL Behring Hyperimmune Serum Product Portfolios and Specifications
Table 83. CSL Behring Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 84. CSL Behring Main Business
Table 85. CSL Behring Latest Developments
Table 86. Grifols Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 87. Grifols Hyperimmune Serum Product Portfolios and Specifications
Table 88. Grifols Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 89. Grifols Main Business
Table 90. Grifols Latest Developments
Table 91. Biotest Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 92. Biotest Hyperimmune Serum Product Portfolios and Specifications
Table 93. Biotest Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 94. Biotest Main Business
Table 95. Biotest Latest Developments
Table 96. Kedrion Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 97. Kedrion Hyperimmune Serum Product Portfolios and Specifications
Table 98. Kedrion Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 99. Kedrion Main Business
Table 100. Kedrion Latest Developments
Table 101. CBPO Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 102. CBPO Hyperimmune Serum Product Portfolios and Specifications
Table 103. CBPO Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 104. CBPO Main Business
Table 105. CBPO Latest Developments
Table 106. Emergent (Cangene) Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 107. Emergent (Cangene) Hyperimmune Serum Product Portfolios and Specifications
Table 108. Emergent (Cangene) Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 109. Emergent (Cangene) Main Business
Table 110. Emergent (Cangene) Latest Developments
Table 111. Kamada Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 112. Kamada Hyperimmune Serum Product Portfolios and Specifications
Table 113. Kamada Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 114. Kamada Main Business
Table 115. Kamada Latest Developments
Table 116. CNBG Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 117. CNBG Hyperimmune Serum Product Portfolios and Specifications
Table 118. CNBG Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 119. CNBG Main Business
Table 120. CNBG Latest Developments
Table 121. Hualan Bio Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 122. Hualan Bio Hyperimmune Serum Product Portfolios and Specifications
Table 123. Hualan Bio Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 124. Hualan Bio Main Business
Table 125. Hualan Bio Latest Developments
Table 126. Shanghai RAAS Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 127. Shanghai RAAS Hyperimmune Serum Product Portfolios and Specifications
Table 128. Shanghai RAAS Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 129. Shanghai RAAS Main Business
Table 130. Shanghai RAAS Latest Developments
Table 131. Sichuan Yuanda Shuyang Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 132. Sichuan Yuanda Shuyang Hyperimmune Serum Product Portfolios and Specifications
Table 133. Sichuan Yuanda Shuyang Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 134. Sichuan Yuanda Shuyang Main Business
Table 135. Sichuan Yuanda Shuyang Latest Developments
Table 136. ADMA Biologics Basic Information, Hyperimmune Serum Manufacturing Base, Sales Area and Its Competitors
Table 137. ADMA Biologics Hyperimmune Serum Product Portfolios and Specifications
Table 138. ADMA Biologics Hyperimmune Serum Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 139. ADMA Biologics Main Business
Table 140. ADMA Biologics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hyperimmune Serum
Figure 2. Hyperimmune Serum Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hyperimmune Serum Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Hyperimmune Serum Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hyperimmune Serum Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hepatitis B Immunoglobulins
Figure 10. Product Picture of Rabies Immunoglobulins
Figure 11. Product Picture of Tetanus Immunoglobulins
Figure 12. Product Picture of Rho(D) Immunoglobulins
Figure 13. Product Picture of Other
Figure 14. Global Hyperimmune Serum Sales Market Share by Type in 2022
Figure 15. Global Hyperimmune Serum Revenue Market Share by Type (2018-2023)
Figure 16. Hyperimmune Serum Consumed in Government Institutions
Figure 17. Global Hyperimmune Serum Market: Government Institutions (2018-2023) & (Kiloton)
Figure 18. Hyperimmune Serum Consumed in Private Sector
Figure 19. Global Hyperimmune Serum Market: Private Sector (2018-2023) & (Kiloton)
Figure 20. Hyperimmune Serum Consumed in Other
Figure 21. Global Hyperimmune Serum Market: Other (2018-2023) & (Kiloton)
Figure 22. Global Hyperimmune Serum Sales Market Share by Application (2022)
Figure 23. Global Hyperimmune Serum Revenue Market Share by Application in 2022
Figure 24. Hyperimmune Serum Sales Market by Company in 2022 (Kiloton)
Figure 25. Global Hyperimmune Serum Sales Market Share by Company in 2022
Figure 26. Hyperimmune Serum Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Hyperimmune Serum Revenue Market Share by Company in 2022
Figure 28. Global Hyperimmune Serum Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Hyperimmune Serum Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Hyperimmune Serum Sales 2018-2023 (Kiloton)
Figure 31. Americas Hyperimmune Serum Revenue 2018-2023 ($ Millions)
Figure 32. APAC Hyperimmune Serum Sales 2018-2023 (Kiloton)
Figure 33. APAC Hyperimmune Serum Revenue 2018-2023 ($ Millions)
Figure 34. Europe Hyperimmune Serum Sales 2018-2023 (Kiloton)
Figure 35. Europe Hyperimmune Serum Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Hyperimmune Serum Sales 2018-2023 (Kiloton)
Figure 37. Middle East & Africa Hyperimmune Serum Revenue 2018-2023 ($ Millions)
Figure 38. Americas Hyperimmune Serum Sales Market Share by Country in 2022
Figure 39. Americas Hyperimmune Serum Revenue Market Share by Country in 2022
Figure 40. Americas Hyperimmune Serum Sales Market Share by Type (2018-2023)
Figure 41. Americas Hyperimmune Serum Sales Market Share by Application (2018-2023)
Figure 42. United States Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Hyperimmune Serum Sales Market Share by Region in 2022
Figure 47. APAC Hyperimmune Serum Revenue Market Share by Regions in 2022
Figure 48. APAC Hyperimmune Serum Sales Market Share by Type (2018-2023)
Figure 49. APAC Hyperimmune Serum Sales Market Share by Application (2018-2023)
Figure 50. China Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Hyperimmune Serum Sales Market Share by Country in 2022
Figure 58. Europe Hyperimmune Serum Revenue Market Share by Country in 2022
Figure 59. Europe Hyperimmune Serum Sales Market Share by Type (2018-2023)
Figure 60. Europe Hyperimmune Serum Sales Market Share by Application (2018-2023)
Figure 61. Germany Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Hyperimmune Serum Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Hyperimmune Serum Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Hyperimmune Serum Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Hyperimmune Serum Sales Market Share by Application (2018-2023)
Figure 70. Egypt Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Hyperimmune Serum in 2022
Figure 76. Manufacturing Process Analysis of Hyperimmune Serum
Figure 77. Industry Chain Structure of Hyperimmune Serum
Figure 78. Channels of Distribution
Figure 79. Global Hyperimmune Serum Sales Market Forecast by Region (2024-2029)
Figure 80. Global Hyperimmune Serum Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Hyperimmune Serum Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Hyperimmune Serum Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Hyperimmune Serum Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Hyperimmune Serum Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Hyperimmune Serum
Figure 2. Hyperimmune Serum Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hyperimmune Serum Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Hyperimmune Serum Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hyperimmune Serum Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hepatitis B Immunoglobulins
Figure 10. Product Picture of Rabies Immunoglobulins
Figure 11. Product Picture of Tetanus Immunoglobulins
Figure 12. Product Picture of Rho(D) Immunoglobulins
Figure 13. Product Picture of Other
Figure 14. Global Hyperimmune Serum Sales Market Share by Type in 2022
Figure 15. Global Hyperimmune Serum Revenue Market Share by Type (2018-2023)
Figure 16. Hyperimmune Serum Consumed in Government Institutions
Figure 17. Global Hyperimmune Serum Market: Government Institutions (2018-2023) & (Kiloton)
Figure 18. Hyperimmune Serum Consumed in Private Sector
Figure 19. Global Hyperimmune Serum Market: Private Sector (2018-2023) & (Kiloton)
Figure 20. Hyperimmune Serum Consumed in Other
Figure 21. Global Hyperimmune Serum Market: Other (2018-2023) & (Kiloton)
Figure 22. Global Hyperimmune Serum Sales Market Share by Application (2022)
Figure 23. Global Hyperimmune Serum Revenue Market Share by Application in 2022
Figure 24. Hyperimmune Serum Sales Market by Company in 2022 (Kiloton)
Figure 25. Global Hyperimmune Serum Sales Market Share by Company in 2022
Figure 26. Hyperimmune Serum Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Hyperimmune Serum Revenue Market Share by Company in 2022
Figure 28. Global Hyperimmune Serum Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Hyperimmune Serum Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Hyperimmune Serum Sales 2018-2023 (Kiloton)
Figure 31. Americas Hyperimmune Serum Revenue 2018-2023 ($ Millions)
Figure 32. APAC Hyperimmune Serum Sales 2018-2023 (Kiloton)
Figure 33. APAC Hyperimmune Serum Revenue 2018-2023 ($ Millions)
Figure 34. Europe Hyperimmune Serum Sales 2018-2023 (Kiloton)
Figure 35. Europe Hyperimmune Serum Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Hyperimmune Serum Sales 2018-2023 (Kiloton)
Figure 37. Middle East & Africa Hyperimmune Serum Revenue 2018-2023 ($ Millions)
Figure 38. Americas Hyperimmune Serum Sales Market Share by Country in 2022
Figure 39. Americas Hyperimmune Serum Revenue Market Share by Country in 2022
Figure 40. Americas Hyperimmune Serum Sales Market Share by Type (2018-2023)
Figure 41. Americas Hyperimmune Serum Sales Market Share by Application (2018-2023)
Figure 42. United States Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Hyperimmune Serum Sales Market Share by Region in 2022
Figure 47. APAC Hyperimmune Serum Revenue Market Share by Regions in 2022
Figure 48. APAC Hyperimmune Serum Sales Market Share by Type (2018-2023)
Figure 49. APAC Hyperimmune Serum Sales Market Share by Application (2018-2023)
Figure 50. China Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Hyperimmune Serum Sales Market Share by Country in 2022
Figure 58. Europe Hyperimmune Serum Revenue Market Share by Country in 2022
Figure 59. Europe Hyperimmune Serum Sales Market Share by Type (2018-2023)
Figure 60. Europe Hyperimmune Serum Sales Market Share by Application (2018-2023)
Figure 61. Germany Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Hyperimmune Serum Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Hyperimmune Serum Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Hyperimmune Serum Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Hyperimmune Serum Sales Market Share by Application (2018-2023)
Figure 70. Egypt Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Hyperimmune Serum Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Hyperimmune Serum in 2022
Figure 76. Manufacturing Process Analysis of Hyperimmune Serum
Figure 77. Industry Chain Structure of Hyperimmune Serum
Figure 78. Channels of Distribution
Figure 79. Global Hyperimmune Serum Sales Market Forecast by Region (2024-2029)
Figure 80. Global Hyperimmune Serum Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Hyperimmune Serum Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Hyperimmune Serum Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Hyperimmune Serum Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Hyperimmune Serum Revenue Market Share Forecast by Application (2024-2029)
